4.1 Article

Exploiting the Concept of Multivalency with 68Ga- and 89Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding

Dominik Summer et al.

BIOCONJUGATE CHEMISTRY (2017)

Article Medicine, Research & Experimental

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT

Jens Sorensen et al.

THERANOSTICS (2016)

Review Oncology

Peptide Receptor Radionuclide Therapy: An Overview

Ashutosh Dash et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2015)

Article Medicine, Research & Experimental

Novel Bifunctional Cyclic Chelator for 89Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates

Chuangyan Zhai et al.

MOLECULAR PHARMACEUTICS (2015)

Review Pharmacology & Pharmacy

Multimerization Improves Targeting of Peptide Radio-Pharmaceuticals

Giuseppe Carlucci et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Review Radiology, Nuclear Medicine & Medical Imaging

Radiopharmaceutical development of radiolabelled peptides

Melpomeni Fani et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Review Biochemistry & Molecular Biology

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Susan Roosenburg et al.

AMINO ACIDS (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides

Peter Laverman et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607

Meltem Ocak et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Targeting of CCK-2 Receptor-Expressing Tumors Using a Radiolabeled Divalent Gastrin Peptide

Jane K. Sosabowski et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Optimised labeling, preclinical and initial clinical. aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides

Wouter A. P. Breeman et al.

NUCLEAR MEDICINE AND BIOLOGY (2008)

Review Physiology

Cholecystokinin and gastrin receptors

Marlene Dufresne et al.

PHYSIOLOGICAL REVIEWS (2006)

Review Endocrinology & Metabolism

Peptide receptors as molecular targets for cancer diagnosis and therapy

JC Reubi

ENDOCRINE REVIEWS (2003)